InBrain Pharma
Founded 2018
France
4 employees
Non Equity Assistance
France
4 employees
Non Equity Assistance
General Information
Get notified when InBrain Pharma moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track InBrain Pharma
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
France Market
About InBrain Pharma
No funding data available for InBrain Pharma yet.
Get notified when InBrain Pharma raises fundingInBrain Pharma Alternatives & Competitors
InBrain Pharma vs
Canther
France
“CANcer Heterogeneity, Plasticity and Resistance to THERapies”
39 employees
Health Care
InBrain Pharma vs
Navigen, Inc.
United States
Discovering and developing D-peptide therapeutics
Series A
14 employees
Health Care, Health and Wellness
InBrain Pharma vs
Octave Biotech Consulting
Switzerland
Octave Biotech Consulting provides strategy and business development assistance to pharmaceutical an...
Seed
1 employees
Biotechnology, Life Sciences
FAQ About InBrain Pharma
InBrain Pharma, a CNS disorders focused biotech, founded in 2018, exploiting through an exclusive worldwide patent license signed with the Northern France TTO, a groundbreaking therapeutic approach of advanced Parkinson’s Disease based on the research work of Pr David DEVOS and Pr Caroline MOREAU de...
InBrain Pharma was founded in 2018.
InBrain Pharma is headquartered in France.
InBrain Pharma has approximately 4 employees.
Top alternatives and competitors to InBrain Pharma include Canther, Navigen, Inc., Octave Biotech Consulting, Capifly , InteliSpark, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InBrain Pharma and Canther are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors InBrain Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.